Penn Center for Innovation

Positive results in first-in-U.S. trial of CRISPR-edited immune cells

Posted on November 8, 2019 — Jessica Jones Gupta

Genetically editing a cancer patient’s immune cells using CRISPR/Cas9 technology, then infusing those cells back into the patient appears safe and feasible based on early data from the first-ever clinical trial to test the approach in humans in the United States. Researchers from the Abramson Cancer Center have infused three participants in the trial thus far—two…

JPOD @ Philadelphia, 365 days later

Posted on November 6, 2019 — Jessica Jones Gupta

One year after the launch of the partnership between Penn and Johnson & Johnson Innovation, the Pennovation Center celebrated the early successes of this innovative program. Read more. (Penn Today)

More Philly tech graduates are staying here. That’s a good thing.

Posted on October 25, 2019 — Jessica Jones Gupta

When it comes to high tech, Philadelphia is no Silicon Valley. We’re not even Boston’s Route 128, bumptiously designated “America’s Technology Region.” But Vijay Kumar, a professor at the University of Pennsylvania School of Engineering, is optimistic about the region’s future as a high-tech center. “I think we are hitting an inflection point in the…

Philadelphia biotech firm spun out of Penn goes public in $74.8M IPO

Posted on — Jessica Jones Gupta

Philadelphia’s Cabaletta Bio Inc. raised $74.8 million in an initial public offering Friday, becoming the region’s first life sciences IPO of 2019. The University of Pennsylvania spinout company sold 6.8 million shares of common stock at $11 per share. Read More on Bizjournals.com

Verix Health raises $8 Million to advance steerable surgical device technology

Posted on October 24, 2019 — Jessica Jones Gupta

Verix Health, formerly Greppo Technologies, announced today the closing of an $8 million Series A financing round led by Ajax Health with participation from Aperture Venture Partners and Western Technology Investment. Verix Health is developing a portfolio of steerable devices enabling minimally invasive delivery of diagnostic and therapeutic tools for solid-organ cancers. The capital will fund…

B.PHL Recap: Making the most of innovation in our backyard

Posted on October 21, 2019 — Jessica Jones Gupta

Philly was abuzz with activity this week with the launch of the first annual B.PHL innovation festival.  The 3-day long festival featured more than 200 panels, workshops, and events and stretched from Temple to Center City, University City, and Grey’s Ferry. Penn participated in B.PHL as a marketing partner, via panels, and as a host…

Philadelphia is having its best year for VC deals since 2000

Posted on October 17, 2019 — Jessica Jones Gupta

Ninety-three percent of raises came from heath and medical care companies. At the close of the third quarter of 2019, Philadelphia is having its best year in terms of deals in the region in nearly two decades, according to a recent PricewaterhouseCoopers (PwC)/CB Insights MoneyTree report. Read more. (Technical.ly Philly)

President’s Innovation Prize deadline is January 24, 2020

Posted on October 16, 2019 — Jessica Jones Gupta

Created by Penn President Amy Gutmann to strengthen Penn’s commitment under the Penn Compact 2020 to innovation, the President’s Innovation Prize will provide a graduating senior, or team of graduating seniors, $100,000 (plus a $50,000 living stipend per team member) to envision and implement an innovative, commercial venture that makes a positive difference in the…

Philadelphia: Here are your nominees for the 2019 Technical.ly Awards

Posted on October 8, 2019 — Jessica Jones Gupta

Voting is open for the awards in categories spanning startups, impact and inventions through Nov. 7, and join us for the celebration event on Dec. 12. Penn startups Lilu and Neuroflow are two of the nominees. Learn more and vote. (Technical.ly Philly)

Gene therapy startup Passage Bio raises $110M Series B, its second raise in less than a year

Posted on September 4, 2019 — Jessica Jones Gupta

Philadelphia-based novel gene therapy startup Passage Bio says it closed a $110 million Series B round of funding, less than seven months after raising a $115.5 million Series A. The company’s latest round of funding was led by Access Biotechnology, with participation from existing investors OrbiMed, Frazier Healthcare Partners, Versant Ventures, Lily Asia Ventures, New…